PRASCO FDA Approval ANDA 216751

ANDA 216751

PRASCO

FDA Drug Application

Application #216751

Application Sponsors

ANDA 216751PRASCO

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001TABLET;ORAL7.5MG0MIRTAZAPINEMIRTAZAPINE
002TABLET;ORAL15MG0MIRTAZAPINEMIRTAZAPINE
003TABLET;ORAL30MG0MIRTAZAPINEMIRTAZAPINE
004TABLET;ORAL45MG0MIRTAZAPINEMIRTAZAPINE

FDA Submissions

UNKNOWN; ORIG1AP2023-01-18STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

PRASCO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216751
            [companyName] => PRASCO
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"7.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"45MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/18\/2023","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.